摘要
本文梳理了境内外含组分百日咳联合疫苗的上市和使用现况,对境内已完成和正在进行的注册临床试验进行了汇总,重点分析了此类品种境内临床试验设计的特点和组织实施的难点,为同类品种后续开展临床试验和技术评价提供参考。
This article reviews the current marketing and usage status of the combined vaccines containing componential pertussis both domestically and foreign.We also summarizes the registered clinical trials that have been completed and ongoing in China.The characteristics of domestic clinical trial design and the difficulties in clinical research and development of the combined vaccines are analyzed further,providing references for subsequent clinical trails and technical evaluation of similar vaccines.
作者
陈艳
刘敏
刘文东
崔灿
王海学
CHEN Yan;LIU Min;LIU Wen-dong;CUI Can;WANG Hai-xue(Center for Drug Evaluation,National Medical Products Administration,Beijing 100076,China)
出处
《中国新药杂志》
CAS
CSCD
北大核心
2024年第21期2234-2238,共5页
Chinese Journal of New Drugs
关键词
组分百日咳疫苗
百白破疫苗
联合疫苗
临床试验
componential pertussis vaccine
pertussis,diphtheria and tetanus vaccines
combined vaccines
clinical trials